Reflexiones sobre el proyecto de real decreto para la disponibilidad de medicamentos en situaciones especiales

Girona Brumós, Lourdes; Juárez Giménez, Juan Carlos.
Farm. hosp ; 33(3): 121-122, mayo-jun. 2009.
Artículo en Español | IBECS (España) | ID: ibc-105291

Documentos relacionados

  1. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
  2. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
  3. Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug Prices.
  4. Proposal To Use VA Price As a Benchmark Is off the Mark.
  5. Expensive Medicine: Drug prices are increasingly hard to swallow. Effective remedies prove elusive.
  6. Meeting in the middle.
  7. Role of Specialty Drugs in Rising Drug Prices for Medicare Part D.
  8. Barriers to Ensuring Access to Affordable Prescription Drugs.
  9. The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study.
  10. Evolving health-care regulations in China.